Suppr超能文献

通过使用血清克拉拉细胞蛋白16作为替代标志物对接触二氧化硅粉尘的工人进行定期筛查,实现矽肺和硅肺结核的二级预防。

Secondary prevention of silicosis and silico-tuberculosis by periodic screening of silica dust exposed workers using serum club cell protein 16 as a proxy marker.

作者信息

Sarkar Kamalesh, Dhatrak Sarang, Sarkar Bidisa, Ojha Umesh Chandra, Raghav Pankaja, Pagdhune Avinash

机构信息

Director ICMR - National Institute of Occupational Health Ahmedabad India.

Department of Poison Information Center ICMR-National Institute of Occupational Health Ahmedabad India.

出版信息

Health Sci Rep. 2021 Sep 22;4(3):e373. doi: 10.1002/hsr2.373. eCollection 2021 Sep.

Abstract

BACKGROUND AND OBJECTIVES

Silicosis is a neglected and widely prevalent occupational disease in India and several other countries such as China, South Africa, Brazil, etc. It is an irreversible, incurable, and progressive disease with high morbidity and mortality, which is mostly caused by occupational exposure to silica dusts. Silicosis is usually detected at an advanced stage, when effective intervention is not possible. But early detection appears to be a cost-effective way to control it. There is a need for some suitable biomarker, which could detect silicosis at an early stage for further necessary intervention. This study aimed to estimate the lung damage in silicotic subjects and its relationship with serum CC16 as a proxy marker. The ultimate objective was to explore whether CC16 could be used as a screening tool for early detection of silicosis.

METHODOLOGY

Radiographs of 117 workers having radiological evidences of silicosis were evaluated in accordance with International Labour Organisation (ILO) Classification of chest radiographs and were categorized as mild, moderate, and severe lung damage using a lung damage scoring system, made for the purpose of this study. The concentration of CC16 in serum was determined by enzyme-linked immunosorbent assay.

RESULT

It was observed that serum CC16 values were significantly decreased in relation to increasing lung damage. The mean ± standard deviation (SD) serum CC16 value in mild lung damage group was 8.4 ± 0.87 ng/mL as compared to 4.0 ± 2.10 ng/mL in moderate and 0.7 ± 0.21 ng/mL in high lung damage groups. On the other hand, CC16 value of control (healthy) population was found to be 16.3 ± 3.8 ng/mL.

CONCLUSION

Result of the study concluded that serum CC16 might be used as a periodic screening tool for early detection of silicosis and for it's secondary prevention. It may be viewed as a new approach toward control of silicosis, and an appropriate policy may be adopted.

摘要

背景与目的

矽肺病在印度以及中国、南非、巴西等其他一些国家是一种被忽视且广泛流行的职业病。它是一种不可逆、无法治愈且呈进行性发展的疾病,发病率和死亡率都很高,主要由职业性接触二氧化硅粉尘引起。矽肺病通常在晚期才被发现,此时已无法进行有效干预。但早期检测似乎是控制该病的一种具有成本效益的方法。需要某种合适的生物标志物,能够在早期检测出矽肺病以便进行进一步的必要干预。本研究旨在评估矽肺患者的肺损伤情况及其与血清CC16作为替代标志物的关系。最终目的是探讨CC16是否可作为早期检测矽肺病的筛查工具。

方法

根据国际劳工组织(ILO)的胸部X光片分类标准,对117名有矽肺病放射学证据的工人的X光片进行评估,并使用为本研究制定的肺损伤评分系统将其分为轻度、中度和重度肺损伤。通过酶联免疫吸附测定法测定血清中CC16的浓度。

结果

观察到血清CC16值随肺损伤程度加重而显著降低。轻度肺损伤组血清CC16的平均值±标准差(SD)为8.4±0.87 ng/mL,中度肺损伤组为4.0±2.10 ng/mL,重度肺损伤组为0.7±0.21 ng/mL。另一方面,对照组(健康人群)的CC16值为16.3±3.8 ng/mL。

结论

该研究结果得出结论,血清CC16可作为早期检测矽肺病及其二级预防的定期筛查工具。它可被视为控制矽肺病的一种新方法,或许可以采用适当的政策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e49/8459027/46a06faaf6fa/HSR2-4-e373-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验